IPAB
Rethink plan to abolish Intellectual Property Appellate Board: Industry groups
The board was set up in 2003 to hear appeals against decisions of the registrar under the Trade Marks Act, 1999, and the Geographical Indications of Goods (Registration and Protection) Act, 1999.
Certain provisions in Trademarks Act unconstitutional: Madras High Court
Madras High Court declared asunconstitutional a sub-section of Trade Marks Act, 1999 whichqualifies a member of Indian Legal Service to the post of vice chairman of IPAB.
Intellectual Property Appellate Board directs Apple Inc to respond on trademark issue
The directive was issued by IPAB here on the rectification petition filed by Erode-based iVoice, engaged in intellectual property rights and mobile applications.
Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar
“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said Ravi Kadam.
Britannia can’t register biscuit brand 'Snax' as a trademark
The IPAB, India’s patent appeals board, on Monday ruled that the Snax biscuit brand of Britannia Industries cannot be trademarked.
Intellectual board upholds CL to Natco for cancer drug
The IPAB has upheld the compulsory licence issued to Natco Pharma for production and marketing of generic version of cancer drug Nexavar.
IPAB set to decide on 16-yr-old dispute over the brand name Original Choice
The producers of Officer’s Choice whisky had challenged the use of the brand name that sounds and looks similar to its name.
Bayer says it will defend its intellectual property rights on cancer drug
Bayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to stay the compulsory license granted to Natco.
RIL in trademark tussle over 'Reliance'
A Surat-based bag maker is fighting a trademark battle with Reliance Industries Ltd insisting that he be allowed to retain the brand name.
IPAB centre likely to come up in Mumbai, Delhi and Kolkata
The government may need to set up permanent centres of the country’s nodal body monitoring disputes related to intellectual property rights and patents in Delhi, Mumbai and Kolkata.
Writ petition says IP tribunal incompetent
A group of patent lawyers have filed a writ petition challenging the legality of the country's highest technical body for intellectual property (IP) disputes saying the members are incompetent to hear IP cases.
SC sets aside tribunal order on Infosys trademark
The SC set aside the Intellectual Property Appellate Board''s decision to turn down Infosys' claim to exclusive ownership of the trademark ''Infosys'' for computer hardware as well.
TELCO loses trade mark battle against T-SERIES
TELCO has lost its trademark violation case against the Super Cassettes Industries in the Delhi High Court which allowed the electronics company to use letter 'T' in its T-SERIES mark, saying it was not its "monopoly".
Novartis to challenge IPAB’s patent decision on Glivec
The Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said its cancer drug Glivec was not patentable.
Madras HC stays appellate board order on dual-SIM patent
The Madras High Court set aside an interim order passed by the Intellectual Property Appellate Board (IPAB), suspending the patent held by Madurai-based engineer Somasundaram Ramkumar for the technology that enables usage of more than one SIM card in mobile handsets, popularly called a dual SIM.
Novartis appeal excludes technical member
The Union Government today informed the Madras High Court that the Intellectual Property Appellate Board (IPAB) could exclude technical member from its bench to hear Swiss Pharma major Novartis AG's appeal against rejection of its application for patent for one of its product.
HC suspends hearings in Novartis' Glivec case
Hearings in Novartis’ appeal against the rejection of patent for its anti-cancer drug Glivec have been suspended yet again, after the Madras High Court restrained the Intellectual Property Appellate Board (IPAB) for four weeks from proceeding with the appeal.
Novartis not to plead Glivec case
Novartis moves to Madras HC seeking removal of former patent chief from IPAB.
Setback for Novartis as Chandrasekaran stays
The Indian Patent Appellate Board dismisses Novartis' objection to the appointment of S Chandrasekaran.
Load More
